ES2029853T5 - Base de unguento y unguento. - Google Patents

Base de unguento y unguento.

Info

Publication number
ES2029853T5
ES2029853T5 ES88100205T ES88100205T ES2029853T5 ES 2029853 T5 ES2029853 T5 ES 2029853T5 ES 88100205 T ES88100205 T ES 88100205T ES 88100205 T ES88100205 T ES 88100205T ES 2029853 T5 ES2029853 T5 ES 2029853T5
Authority
ES
Spain
Prior art keywords
ointment
gel ointment
base
resistant
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88100205T
Other languages
English (en)
Other versions
ES2029853T3 (es
Inventor
Takuzo Kamishita
Takashi Miyazaki
Yoshihide Okuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toko Yakuhin Kogyo KK
Original Assignee
Toko Yakuhin Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11655051&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2029853(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toko Yakuhin Kogyo KK filed Critical Toko Yakuhin Kogyo KK
Application granted granted Critical
Publication of ES2029853T3 publication Critical patent/ES2029853T3/es
Publication of ES2029853T5 publication Critical patent/ES2029853T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UNA BASE DE UNGUENTO GEL, QUE TIENE VISCOSIDAD ESTABLE Y RESISTENTE A LA LUZ, QUE COMPRENDE UNA DISOLUCION ACUOSA DE POLIMERO DE CARBOXIVINILO Y UN AMINOACIDO, EN CANTIDAD EFICAZ PARA AUMENTAR LA VISCOSIDAD DE LA DISOLUCION ACUOSA DE POLIMERO DE CARBOXIVINILO, Y UN UNGUENTO GEL, CONTIENE UNA SUSTANCIAL MEDICINAL ACTIVA Y LA BASE DE UNGUENTO GEL COMO SE EXPLICO ANTES, QUE TIENE VISCOSIDAD ESTABLE Y RESISTENTE A LA LUZ, EN UN INTERVALO DE PH QUE NO PRODUCE NINGUNA IRRITACION A LAS MEMBRANAS VISCOSAS Y A LA PIEL
ES88100205T 1987-01-14 1988-01-09 Base de unguento y unguento. Expired - Lifetime ES2029853T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62007044A JPS63174924A (ja) 1987-01-14 1987-01-14 軟膏基剤および軟膏剤

Publications (2)

Publication Number Publication Date
ES2029853T3 ES2029853T3 (es) 1992-10-01
ES2029853T5 true ES2029853T5 (es) 2000-07-01

Family

ID=11655051

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88100205T Expired - Lifetime ES2029853T5 (es) 1987-01-14 1988-01-09 Base de unguento y unguento.

Country Status (8)

Country Link
US (1) US4983386A (es)
EP (1) EP0275054B2 (es)
JP (1) JPS63174924A (es)
AT (1) ATE66140T1 (es)
AU (1) AU607959B2 (es)
CA (1) CA1324078C (es)
DE (1) DE3864149D1 (es)
ES (1) ES2029853T5 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel
US5158761A (en) * 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
WO1990013284A1 (en) * 1989-04-29 1990-11-15 Fisons Plc Pharmaceutical composition containing sodium cromoglycate
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
EP0711175B1 (en) * 1993-04-30 2001-08-29 Eastern Virginia Medical School Topical compositions for re-epitheliazation of persistent epithelial defects
US5595753A (en) * 1995-04-14 1997-01-21 President And Fellows Of Harvard College Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract
US5980866A (en) * 1996-03-15 1999-11-09 Juridical Foundation The Chemosero-Therapeutic Research Institute Tissue adhesive suitable for spray application
US8048875B1 (en) 1997-02-24 2011-11-01 S.L.A. Pharma Ag Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
EP1250927A3 (en) * 1997-02-24 2003-03-26 S.L.A. Pharma AG Pharmaceutical composition for topical application comprising nifedipine
DE19744113A1 (de) * 1997-10-06 1999-04-15 Mann Gerhard Chem Pharm Fab Dexamethason-Gel
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
JP4577996B2 (ja) * 2001-01-18 2010-11-10 株式会社ノエビア 皮膚化粧料
EP1421940A4 (en) * 2001-08-09 2006-02-08 Sekisui Chemical Co Ltd MEDICAL COMPOSITION FOR EXTERNAL USE FOR THE TREATMENT OF DERMATOSES
WO2004024187A2 (en) * 2002-09-13 2004-03-25 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
WO2004090613A1 (ja) * 2003-04-03 2004-10-21 Seed Co., Ltd. 薬物徐放性眼用レンズ及びそれに用いる保存液
FR2860718B1 (fr) * 2003-10-09 2006-02-24 Jean Pascal Conduzorgues Nouvelle formulation et ses applications dans le domaines cosmetiques ou pharmaceutiques
WO2007013591A1 (ja) * 2005-07-29 2007-02-01 Santen Pharmaceutical Co., Ltd. ゲル状組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム
US20080226724A1 (en) * 2007-01-19 2008-09-18 Genentech, Inc. Prevention of hydrogel viscosity loss
GB2447012B (en) 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
JP7214751B2 (ja) * 2018-01-08 2023-01-30 チー リウ アネモシドｂ４の直腸粘膜投与製剤及びその製造方法
KR102219317B1 (ko) * 2020-10-06 2021-02-24 엘앤피코스메틱 (주) 천연 보습인자를 이용하여 형성된 미셀 복합체를 포함하는 화장료 조성물의 제조방법 및 이로부터 제조된 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102995A (en) * 1976-05-13 1978-07-25 Westwood Pharmaceuticals Inc. Tar gel formulation
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
AU8409582A (en) * 1981-06-15 1982-12-23 Alcon Laboratories, Inc. Urea and carboxyvinyl polymers gel compositions
JPS5920217A (ja) * 1982-07-27 1984-02-01 Kawaken Fine Chem Co Ltd 尿素を安定に含む水性ゼリ−状組成物
JPS5948413A (ja) * 1982-09-14 1984-03-19 Grelan Pharmaceut Co Ltd クリダナクを含有する消炎鎮痛外用剤
EP0162007A1 (de) * 1984-04-18 1985-11-21 Geriaco AG Stabiles, lagerungsfähiges Insulinpräparat zur Behandlung von Akne vulgaris
JPH0745393B2 (ja) * 1986-01-08 1995-05-17 サンスタ−株式会社 弱酸性ゲル状化粧料

Also Published As

Publication number Publication date
AU1022588A (en) 1988-07-21
EP0275054B2 (en) 2000-01-26
EP0275054A1 (en) 1988-07-20
ATE66140T1 (de) 1991-08-15
JPH0555483B2 (es) 1993-08-17
AU607959B2 (en) 1991-03-21
CA1324078C (en) 1993-11-09
US4983386A (en) 1991-01-08
EP0275054B1 (en) 1991-08-14
JPS63174924A (ja) 1988-07-19
DE3864149D1 (de) 1991-09-19
ES2029853T3 (es) 1992-10-01

Similar Documents

Publication Publication Date Title
ES2029853T5 (es) Base de unguento y unguento.
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
PT723437E (pt) Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes
FR2636339B1 (fr) Gel aqueux a base d'acide hyaluronique et d'acide desoxyribonucleique utilisable en cosmetique, et procede de preparation
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
DE3762867D1 (de) Mesomorpher polymerwirkstoff, verwendungsfaehig zur nichtlinearoptik.
ATE135216T1 (de) Verwendung von spiperone-derivate zur immunosuppression
MC2094A1 (fr) Medicament contenant de l'acide dihydrolipoique en tant que substance active,procede de preparation
DK0457849T3 (da) Klæbemiddel til elektrotransport
ATE54824T1 (de) System zur arzneistoffabgabe mit erhoehter bioakzeptanz.
ES2061826T3 (es) Un procedimiento de preparacion de derivados n-2,3-butadienil triaminoalcanos.
ATE56139T1 (de) Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.
ATE27914T1 (de) Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung.
ES2099272T3 (es) Composiciones oftalmicas a base de oxicam o de derivados de oxicam.
DK0431465T3 (da) Vandig dialyse- og skylleopløsning
ES2060057T3 (es) Soluciones acuosas conteniendo proteina.
ATE108326T1 (de) Wässerige desmopressin-cmc enthaltende arzneizubereitung.
DE3677511D1 (de) Oligosaccharide, verfahren zu ihrer herstellung und ihre anwendung.
PT96828A (pt) Processo para a preparacao de um agente para a terapia de gangrena diabetica,contendo o factor xiii de coagulacao do sangue
PT1126848E (pt) Recipiente plastico contendo formulacoes estabilizadas de drogas
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
ES2033927T3 (es) Utilizacion de la forma farmaceutica de "gel" conteniendo acido n-(2,6-cicloro-m-tolil)-antranilico (acido meclofenamico) utilizable en terapia de uso topico.
DE3685988D1 (de) Verwendung von "naftidrofuryl" zur behandlung von neuropathien.
FR2648458B1 (fr) Acide diallyloxyacetique et ses sels d'addition basiques, leur procede de preparation et leur application comme agent reticulant

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 275054

Country of ref document: ES